2011年至2013年成都地区医院抗肿瘤药物应用分析

摘要

目的：分析2011年至2013年成都地区11家医院抗肿瘤药物临床应用情况，为临床合理用药提供依据，为生产、营销和使用提供参考。方法统计“医院处方分析”课题中成都地区11家样本医院提供的2011年至2013年抗肿瘤药物中各大类及品种金额、份额、增长率、复合年增长率、用药频度( DDDs )等，结合临床应用进行分析。结果3年来抗肿瘤药物需求量迅速增长，销售金额、DDDs呈上升趋势，抗代谢类药物一直居销售排行榜首，其中替吉奥近两年来药物单品种销售金额及DDDs均居首位。结论成都地区医院抗肿瘤药物用量呈上升趋势，开发高效、低毒、价廉的抗肿瘤药物是当今迫切的任务。%Objective To investigate the utilization trend of anti-tumor agents in the 11 hospitals in Chengdu for reference of clinical rational drug use during 2011-2013. Methods Data for anti-tumor agents in 11 hospitals of Chengdu during 2011-2013 were used to count the sales, shares, growth rates, DDDs and compound annual growth rate of statistical categories and varieties, which were ana-lyzed by combination with their application in clinic. Results The anti-tumor agents used in Chengdu hospitals continue to grow up during the 3 years. The anti-metabolism agents sales has been the first during 3 years, and the sales amount and DDDs of the maxi-mum is TS-1. Conclusion The use of anti-tumor drugs assumes an increasingly important role in clinical treatment. Development of high efficiency, low toxicity, low price of the anti-tumor agents is the urgent task.